Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imatinib Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00511303
What this trial is testing

Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
University of Bologna 200
Testing effectiveness (Phase 2)Looking for participantsNCT07559370
What this trial is testing

Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria

Who this might be right for
Malaria (Plasmodium Falciparum)
Victoria Biomedical Research Institute 1,116
Testing effectiveness (Phase 2)Study completedNCT00510653
What this trial is testing

Gleevec Study for Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
M.D. Anderson Cancer Center 73
Testing effectiveness (Phase 2)Study completedNCT00570635
What this trial is testing

XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib

Who this might be right for
Gastrointestinal Stromal TumorsGastrointestinal Neoplasms
Exelixis 16
Testing effectiveness (Phase 2)Study completedNCT00117299
What this trial is testing

PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib

Who this might be right for
Sarcoma
University of Helsinki 45
Testing effectiveness (Phase 2)Study completedNCT01275222
What this trial is testing

Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 117
Not applicableStudy completedNCT01475110
What this trial is testing

Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib

Who this might be right for
Chronic Myeloid Leukaemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 19
Testing effectiveness (Phase 2)Study completedNCT00053248
What this trial is testing

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
OHSU Knight Cancer Institute 16
Large-scale testing (Phase 3)Study completedNCT01289028
What this trial is testing

Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 125
Testing effectiveness (Phase 2)Study completedNCT00254267
What this trial is testing

Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors

Who this might be right for
Advanced Gastrointestinal Stromal Tumor
Amgen 35
Testing effectiveness (Phase 2)Ended earlyNCT02398825
What this trial is testing

Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib

Who this might be right for
Chronic Myeloid LeukemiaChronic PhaseAdults
Gruppo Italiano Malattie EMatologiche dell'Adulto 14
Large-scale testing (Phase 3)Study completedNCT00123474
What this trial is testing

Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML

Who this might be right for
Myeloid Leukemia, Chronic, Chronic-Phase
Bristol-Myers Squibb 724
Large-scale testing (Phase 3)Study completedNCT02260505
What this trial is testing

Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)

Who this might be right for
Gastrointestinal Stromal TumorsResected Gastrointestinal Stromal TumorsNon-metastatic+2 more
Centre Leon Berard 136
Testing effectiveness (Phase 2)UnknownNCT00146913
What this trial is testing

AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year

Who this might be right for
Chronic Myeloid Leukemia
Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT00265798
What this trial is testing

Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate

Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT01039519
What this trial is testing

A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor
Synta Pharmaceuticals Corp. 27
Post-approval studies (Phase 4)Study completedNCT01368523
What this trial is testing

Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 19
Not applicableEnded earlyNCT01073644
What this trial is testing

Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 3
Testing effectiveness (Phase 2)Study completedNCT01844765
What this trial is testing

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

Who this might be right for
Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)UnknownNCT00112775
What this trial is testing

BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate

Who this might be right for
Leukemia
Jonsson Comprehensive Cancer Center
Next Page